Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
GeneDx Holdings
AddedFeb 19, 2024
UpdatedJun 18, 2026
GeneDx Holdings

GeneDx Holdings

Public

Connecticut-based GeneDx, a software company merging diagnostics and data science for personalized health insights.

HQ
Stamford, CT, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Founded in Stamford, Connecticut, GeneDx Holdings is a pioneering software company dedicated to merging diagnostics and data science to deliver personalized health insights. The company’s core mission is to provide comprehensive genomic insights and precision medicine that improve health outcomes. GeneDx offers services that inform diagnosis, direct treatment, and enhance drug discovery through advanced genetic testing. Their market focus includes healthcare providers, patients, and caregivers seeking actionable genetic information.

GeneDx has attracted notable investors and industry experts who support its innovative approach to healthcare. The company has achieved significant milestones in genomic diagnostics, contributing to improved patient outcomes and advancing the field of precision medicine. By leveraging decades of genomic expertise and clinical data interpretation, GeneDx has made a substantial impact on the accessibility and effectiveness of genetic testing, positioning itself as a leader in the integration of diagnostics and data science.

GeneDx Holdings - Similar Companies

Invitae logo

Invitae

invitae.com

Geneicd logo

Geneicd

Genetica logo

Genetica

genetica.asia

Gene Solutions logo

Gene Solutions

Myriad Genetics logo

Myriad Genetics

myriad.com

23andMe logo

23andMe

23andme.com

My Gene Counsel logo

My Gene Counsel

mygenecounsel.com

Genomenon logo

Genomenon

genomenon.com

Allelica logo

Allelica

allelica.com

Color logo

Color

color.com

Informeddna logo

Informeddna

informeddna.com

Personal Genome Diagnostics logo

Personal Genome Diagnostics

personalgenome.com

Fulgent Genetics logo

Fulgent Genetics

Juno Diagnostics logo

Juno Diagnostics

Gencove logo

Gencove

gencove.com

GeneDx Holdings - Quick Facts

Who are GeneDx Holdings' competitors?

Companies similar to GeneDx Holdings include Invitae, Geneicd, Genetica and Gene Solutions.

When was GeneDx Holdings founded?

GeneDx Holdings was founded in 2017.

Where is GeneDx Holdings' headquarters located?

GeneDx Holdings' headquarters is located in Stamford, CT, US.

When was GeneDx Holdings' last funding round?

GeneDx Holdings' most recent funding round was for $150M (USD) in January 2023.

How much has GeneDx Holdings raised to-date?

As of Jan 27, 2023, GeneDx Holdings has raised a total of $941M (USD).

How many employees does GeneDx Holdings have?

GeneDx Holdings has 919 employees as of Feb 5, 2024.

GeneDx Holdings - Classification

Ownership
  • Private
Technology
  • Analytics
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Main Product
  • Genetic Testing
Tags
  • Healthcare Providers
  • Healthtech
  • Patients
Unique IDs
  • ein: 851966622
  • secCik: 0001818331
  • ticker: WGS
  • ticker: WGSWW
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 8000Health Services
Show 11 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 5000Wholesale Trade-durable Goods
  • 6000Depository Institutions
  • 6700Holding And Other Investment Offices
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
  • 7372Prepackaged Software